The average sentiment for articles published by this News Source are below.

Anger: Red
Disgust: Olive
Fear: Green
Joy: Gold
Sadness: Blue
View Post

ACETO Corporation Schedules First Quarter Fiscal 2018 Financial Results News Release and Conference Call

In Business, Finance, Healthcare, Legal by Aceto CorporationLeave a Comment

Tech News Keywords: , , , , , , ,

PORT WASHINGTON, N.Y., Oct. 20, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the first quarter of fiscal 2018 ended September 30, 2017 after the stock market close on Thursday, November 2, 2017. Management will host a conference call to discuss the operating and financial results at 9:00 a.m. ET on Friday, November 3, 2017.  To participate in the conference call, please dial 877-317-6789 or 412-317-6789 approximately 10 minut... Read More
View Post

ACETO Appoints William C. Kennally, III President and CEO

In Business, Government, Healthcare, Legal, Science & Nature by Aceto CorporationLeave a Comment

Tech News Keywords: , , , , , , , , ,

PORT WASHINGTON, N.Y., Sept. 27, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed William C. Kennally, III, as President and Chief Executive Officer effective October 2, 2017. Salvatore Guccione, ACETO’s Chief Executive Officer has stepped down from all positions with Aceto effective today.   “As we continue to transition the company to one focused on human health and specifically finished dosage ... Read More
View Post

ACETO to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

In Business, Healthcare by Aceto CorporationLeave a Comment

Tech News Keywords: , , , , , ,

PORT WASHINGTON, N.Y., Sept. 05, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Sal Guccione, President and CEO, is scheduled to participate in a fireside chat at the Morgan Stanley 15th Annual Global Healthcare Conference on Tuesday, September 12, 2017 at 4:40 PM ET. A webcast of the presentation will be available under Events and Presentations in the investor relations section of the company’s website at ... Read More
View Post

ACETO Reports Fiscal 2017 Fourth Quarter and Full Year Results

In Business, Government, Healthcare, Legal, Science & Nature by Aceto CorporationLeave a Comment

Tech News Keywords: , , , , , , , , ,

PORT WASHINGTON, N.Y., Aug. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fourth quarter and fiscal year ended June 30, 2017. Fiscal 2017 versus Fiscal 2016 Net sales of $638.3 million versus $558.5 million, a 14.3% increase Gross profit of $140.8 million versus $142.8 million, a 1.4% decrease ... Read More
View Post

ACETO Corporation Schedules Fourth Quarter & Fiscal 2017 Financial Results News Release and Conference Call

In Business, Finance, Healthcare, Legal by Aceto CorporationLeave a Comment

Tech News Keywords: , , , , , , ,

PORT WASHINGTON, N.Y., Aug. 11, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the fourth quarter and full year of fiscal 2017 ended June 30, 2017 after the stock market close on Thursday, August 24, 2017. Management will host a conference call to discuss the operating and financial results at 9:00 a.m. ET on Friday, August 25, 2017.  To participate in the conference call, please dial 877-317-6789 or 412-317-6789 approximately 10 minutes ... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, Announces Product Launches

In Business, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , ,

PORT WASHINGTON, N.Y., July 21, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, recently launched: Ramipril Capsules, 1.25mg, 2.5mg, 5mg, and 10mg, an FDA-approved generic version of the reference listed drug, Altace® from Pfizer, which is indicated for the treatment of hypertension. Losartan Potassium Tablets, 25mg and 50mg, an FDA-approved generic version... Read More
View Post

ACETO to Present at the Singular Summer Solstice Conference

In Business, Healthcare by Aceto Corporation

Tech News Keywords: , , , , , ,

PORT WASHINGTON, N.Y., July 07, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health Products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Sal Guccione, president and CEO, will present at the Singular Summer Solstice Conference on Thursday, July 13, 2017 at 9:45AM ET. A webcast of the presentation will be available under Events and Presentations in the investor relations section of the company’s website at ... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, Launches Chlorthalidone Tablets, 25 mg and 50 mg, and Glipizide Extended Release Tablets, 2.5 mg, 5 mg and 10 mg

In Business, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , ,

PORT WASHINGTON, N.Y., June 20, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched an FDA-approved generic version of Chlorthalidone Tablets, 25 mg and 50 mg, which are indicated for the management of hypertension.  Chlorthalidone Tablets, 25 mg and 50 mg, had U.S. sales of approximately $138 million for the 12 months ending April 2017, according to IMS Health. In addition, Risin... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, Launches Atomoxetine Capsules, 10, 18, 25, 40, 60, 80 & 100 mg

In Business, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , ,

PORT WASHINGTON, N.Y., May 31, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched Atomoxetine Capsules, 10, 18, 25, 40, 60, 80 and 100 mg, an AB rated, generic version of the reference listed drug, Strattera® Capsules from Eli Lilly and Co.  Atomoxetine Capsules, which are indicated for the treatment of Attention-deficit/hyperactivity disorder (ADHD), had U.S. sales of approximately $1.1 billion for the 12 months ending April 2017, according... Read More
View Post

ACETO Reports Fiscal 2017 Third Quarter Results

In Business, Government, Healthcare, Legal, Science & Nature by Aceto Corporation

Tech News Keywords: , , , , , , , , ,

Management to Host Conference Call on May 5, 2017 at 9:00 a.m. ET PORT WASHINGTON, N.Y., May 04, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2017 ended March 31, 2017. Third Quarter Fiscal 2017 versus Third Quarter Fiscal 2016 Net sales of $190.1 million versus $157.9 million, a 20.4% inc... Read More
View Post

ACETO Corporation Schedules Third Quarter Fiscal 2017 Financial Results News Release and Conference Call

In Business, Finance, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , , ,

PORT WASHINGTON, N.Y., April 21, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the third quarter of fiscal 2017 ended March 31, 2017 after the stock market close on Thursday, May 4, 2017. Management will host a conference call to discuss the operating and financial results at 9:00am ET on Friday, May 5, 2017.  To participate in the conference call, please dial 877-317-6789 or 412-317-6789 approximately 10 minutes prior to the call.  Pl... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, Launches Zileuton Extended Release Tablets, 600 mg

In Business, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , ,

PORT WASHINGTON, N.Y., March 31, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched Zileuton Extended Release Tablets, 600 mg.  Rising holds the Abbreviated New Drug Application (ANDA) for this drug, an AB-rated generic version of Zyflo CR® Tablets from Chiesi USA, which is indicated for the chronic treatment of asthma.  Zileuton Extended Release Tablets, 600 mg, had U.S. sales of approximately $75 million for the 12 months en... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, Launches Capecitabine Tablets, 150 & 500 mg

In Business, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , ,

PORT WASHINGTON, N.Y., March 28, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched Capecitabine Tablets, 150 & 500 mg, an AB-rated generic version of Xeloda® Tablets from Hoffman La Roche.  Capecitabine Tablets, 150 & 500 mg, which are indicated for the treatment of metastatic breast cancer, had U.S. sales of approximately $393 million for the 12 months ending December 2016, according to IMS Health. ... Read More
View Post

ACETO Corporation Schedules Second Quarter Fiscal 2017 Financial Results News Release and Conference Call

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article PORT WASHINGTON, N.Y., Jan. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2017 ended December 31, 2016 after the stock market close on Thursday, February 2, 2017. Management will host a conference call ... Read More
View Post
Number of Items Identified: 7
Item #Item NameScoreItem Classification
1building complex0.651
2medical building0.629
3building0.851
4azure color0.953
5gray color0.797

ACETO Completes Acquisition of Generic Products and Related Assets of Citron Pharma and Lucid Pharma

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article ACETO Receives Hart-Scott-Rodino Antitrust Clearance for Citron Transaction PORT WASHINGTON, N.Y., Dec. 21, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has, through its wholly-owned subsidiary Rising Pharmaceuticals, completed the acquisition of generic products and rela... Read More
View Post

ACETO to Participate at Upcoming Investor Conferences in January

In Business, Events, Finance, Healthcare by Aceto Corporation

Tech News Keywords: , , , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article PORT WASHINGTON, N.Y., Dec. 20, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that management will participate in two investor conferences. CJS Securities "New Ideas for the New Year" Investor Conference on Wednesday, January 11, 2017 in New York... Read More
View Post
Number of Items Identified: 5
Item #Item NameScoreItem Classification
1official0.644person, official
2person0.718
3orange color0.821
4azure color0.678

ACETO Comments on Legal Proceedings affecting the Generic Pharmaceuticals Industry

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article PORT WASHINGTON, N.Y., Dec. 15, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET) commented today on recent announcements impacting the generic pharmaceuticals industry.  The State of Connecticut announced today that it and nineteen other states have filed a civil complaint against six generic drug manufacturers or suppliers, including Citron Pharma LLC,  alleging violations of the antitrust laws relating to the sale of two drugs, doxycycline hyclate delayed release (“Doxy DR”) and glybu... Read More
View Post
Number of Items Identified: 6
Item #Item NameScoreItem Classification
1official0.748person, official
2person0.868
3anchorperson0.667
4ultramarine color0.831
5orange color0.625
Number of Faces Detected: 1
Face #Max AgeMin AgeAge CertaintyGenderGender CertaintyIdent NameIdent ClassificationIdent Score
164550.380632MALE0.993307Kemal Dervişpeople, artists, kemal0.924142

ACETO Board of Directors Declares Quarterly Cash Dividend

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article PORT WASHINGTON, N.Y., Dec. 01, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.065 per common share.  This quarterly cash dividend will be distributed on December 22, 2016 to shareholders of record as of December 12, 2016.... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, to Launch Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5%

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article PORT WASHINGTON, N.Y., Nov. 17, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5% an FDA-approved generic version of Valeant International’s Benz... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, to Launch Oxybutynin Chloride Extended-Release Tablets, USP

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article PORT WASHINGTON, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Oxybutynin Chloride Extended-Release Tablets, USP, an FDA-approved generic version of Janssen Pharmaceuticals, Inc.’s Ditropan XL T... Read More
View Post
Number of Items Identified: 9
Item #Item NameScoreItem Classification
1guitar pick0.709device, guitar pick
2device0.874
3pick (for string instrument)0.684device, pick (for string instrument)
4blue color0.996

ACETO Corporation to Hold Conference Call on November 3, 2016 at 9:00 a.m. ET

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article Conference Call Previously Scheduled on November 4 at 9:00 a.m. ET PORT WASHINGTON, N.Y., Nov. 02, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that the date of the Company’s conference call to discuss the operating and financial results for the first qu... Read More
View Post
Number of Items Identified: 9
Item #Item NameScoreItem Classification
1guitar pick0.709device, guitar pick
2device0.874
3pick (for string instrument)0.684device, pick (for string instrument)
4blue color0.996

ACETO Reports Fiscal 2017 First Quarter Results

In Business, Events, Finance, Government, Healthcare, Legal, Science & Nature by Aceto Corporation

Tech News Keywords: , , , , , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article Separately Company Announces Acquisition of Generic Products and Related Assets of Citron Pharma Management to Host Conference Call on November 3, 2016 at 9:00 a.m. ET PORT WASHINGTON, N.Y., Nov. 02, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, ... Read More
View Post

ACETO to Acquire Generic Products and Related Assets of Citron Pharma and Lucid Pharma

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , , , ,

[responsivevoice_button voice="US English Female" buttontext="Play"] / Go to Source Article Transaction Significantly Enlarges ACETO’s Finished Dosage Generic Drug Business Combines complementary asset-light business models, products and partners Adds significant value of 47 commercialized generic drug products, and 31 approved and yet-to-be launched products Adds 33 pipeline projects; 29 ANDAs to be owned by Rising Pharmaceuticals ... Read More
View Post
Number of Items Identified: 11
Item #Item NameScoreItem Classification
1web site0.834device, machine, computer, web site
2computer0.839
3machine0.839
4device0.901
5video display0.629
6electronic device0.633
7emerald color0.731
8ultramarine color0.677

ACETO Subsidiary, Rising Pharmaceuticals, to Launch Fluocinolone Acetonide OTIC Oil, 0.01%

In Business, Events, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , ,

PORT WASHINGTON, N.Y., Sept. 16, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Fluocinolone Acetonide OTIC Oil, 0.01%, an FDA approved generic version of Hill Dermaceuticals Inc.’s DermOtic®. According to IMS Health data, U.S. market sales for Fluocinolone Acetonide OTIC Oil, which is used in the treatment of chronic eczematous external otitis, were ... Read More
View Post
Number of Items Identified: 11
Item #Item NameScoreItem Classification
1web site0.839device, machine, computer, web site
2computer0.843
3machine0.843
4device0.903
5monitor (computer)0.614
6video display0.646
7electronic device0.65
8emerald color0.741
9ultramarine color0.691

ACETO Appoints William C. Kennally, III to the Board of Directors

In Business, Government, Healthcare by Aceto Corporation

Tech News Keywords: , , , , , ,

PORT WASHINGTON, N.Y., Sept. 06, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed William C. Kennally, III, 61 years old, to its Board of Directors, effective September 6, 2016. Chairman of the Board, Albert Eilender, commented, “We are pleased to welcome Bill to the ACETO board.  He has deep, multi-faceted experience in pharmaceutical sales, general management, and business leadership gained over a 37-year distinguished career.  We look forward... Read More
View Post
Number of Items Identified: 11
Item #Item NameScoreItem Classification
1web site0.834device, machine, computer, web site
2computer0.839
3machine0.839
4device0.901
5video display0.629
6electronic device0.633
7emerald color0.731
8ultramarine color0.677

ACETO to Present at the Morgan Stanley 2016 Global Healthcare Conference

In Business, Events, Healthcare by Aceto Corporation

Tech News Keywords: , , , , , ,

PORT WASHINGTON, N.Y., Sept. 06, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Sal Guccione, President and CEO, will present at the Morgan Stanley 2016 Global Healthcare Conference on Tuesday, September 13, 2016 at 4:05 PM ET. A webcast of the presentation will be available under Events and Presentations in the investor relations section of the company’s website at www.aceto.com. ABOUT ACETO... Read More
View Post
Number of Items Identified: 11
Item #Item NameScoreItem Classification
1web site0.839device, machine, computer, web site
2computer0.843
3machine0.843
4device0.903
5monitor (computer)0.614
6video display0.646
7electronic device0.65
8emerald color0.741
9ultramarine color0.691

ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results

In Business, Events, Government, Healthcare, Legal, Science & Nature by Aceto Corporation

Tech News Keywords: , , , , , , , , ,

PORT WASHINGTON, N.Y., Aug. 25, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fourth quarter and fiscal year ended June 30, 2016. Fiscal 2016 versus Fiscal 2015 Net sales of $558.5 million versus $547.0 million, a 2.1% increase Gross profit of $142.8 million versus $135.4 million, a 5.4% increase Net inco... Read More
View Post

ACETO Board of Directors Increases Quarterly Cash Dividend by 8.3%

In Business, Events, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , ,

PORT WASHINGTON, N.Y., Aug. 25, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has increased its regular quarterly dividend to $0.065 per common share.  This quarterly cash dividend will be distributed on September 20, 2016 to shareholders of record as of September 9, 2016. ABOUT ACETO ACETO Corporation, incorporated in 1947 and with offices and operations in 10 countries, is enga... Read More
View Post

ACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01%

In Business, Events, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , ,

PORT WASHINGTON, N.Y., Aug. 23, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, has launched two new products, Fluocinolone Acetonide Body Oil, 0.01%, an FDA approved generic version of Derma-Smoothe/FS® Body Oil, and Fluocinolone Acetonide Scalp Oil, 0.01%, an FDA approved generic version of Derma-Smoothe/FS® Scalp Oil. ... Read More
View Post
Number of Items Identified: 11
Item #Item NameScoreItem Classification
1web site0.839device, machine, computer, web site
2computer0.843
3machine0.843
4device0.903
5monitor (computer)0.614
6video display0.646
7electronic device0.65
8emerald color0.741
9ultramarine color0.691

ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , ,

PORT WASHINGTON, N.Y., Aug. 12, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the fourth quarter of fiscal 2016 and the full fiscal year ended June 30, 2016 after the stock market close on Thursday, August 25, 2016. Management will host a conference call to discuss the operating and financial results at 9:00am ET on Friday, August 26, 2016.  To participate in the conference call, please dial (800) 446-1671 or (847) 413-3362 approximatel... Read More
View Post
Number of Items Identified: 11
Item #Item NameScoreItem Classification
1web site0.834device, machine, computer, web site
2computer0.839
3machine0.839
4device0.901
5video display0.629
6electronic device0.633
7emerald color0.731
8ultramarine color0.677

ACETO Names Walter Kaczmarek III Chief Operating Officer

In Business, Education, Events, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , , , ,

PORT WASHINGTON, N.Y., July 18, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of  products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has named Walter J. Kaczmarek III  its Chief Operating Officer effective August 1, 2016.  Mr. Kaczmarek will assume responsibility for managing day-to-day operations at ACETO’s three business segments, reporting to Salvatore Guccione, Chief Executive Officer. Mr. Kaczmarek, age 57, possesses more than 25 years of experience in the pharmaceutical industry s... Read More
View Post

ACETO to Present in June Conferences

In Business, Events, Healthcare by Aceto Corporation

Tech News Keywords: , , , , , , ,

PORT WASHINGTON, N.Y., May 23, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced it will participate in two investor conferences taking place in June. 13th Annual Craig-Hallum Institutional Investor Conference in Minneapolis, MN on June 1.  Salvatore Guccione, President and CEO will host one-on-one meetings throughout the day.   Jefferies 2016 Healthcare Conference ... Read More
View Post
Number of Items Identified: 11
Item #Item NameScoreItem Classification
1web site0.839device, machine, computer, web site
2computer0.843
3machine0.843
4device0.903
5monitor (computer)0.614
6video display0.646
7electronic device0.65
8emerald color0.741
9ultramarine color0.691

ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News Release and Conference Call

In Business, Events, Finance, Government, Healthcare, Legal by Aceto Corporation

Tech News Keywords: , , , , , , , ,

PORT WASHINGTON, N.Y., Oct. 21, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the first quarter of fiscal 2017 ended September 30, 2016 after the stock market close on Thursday, November 3, 2016. Management will host a conference call to discuss the operating and financial results at 9:00am ET on Friday, November 4, 2016.  To participate in the conference call, please dial (800) 446-1671 or (847) 413-3362 approximately 10 min... Read More